Scinovex
article Open AccessTop 1% cited

Prevalence in the United States of <i>aac(6</i> ′ <i>)</i> - <i>Ib</i> - <i>cr</i> Encoding a Ciprofloxacin-Modifying Enzyme

Antimicrobial Agents and Chemotherapy · 2006 · Vol. 50(11) · pp. 3953–3955
Chi Hye ParkAri RobicsekGeorge A. JacobyDaniel F. SahmDavid C. Hooper

Abstract

Among 313 Enterobacteriaceae from the United States with a ciprofloxacin MIC of >/=0.25 microg/ml and reduced susceptibility to ceftazidime, aac(6')-Ib was present in 50.5% of isolates, and of these, 28% carried the cr variant responsible for low-level ciprofloxacin resistance. aac(6')-Ib-cr was geographically widespread, stable over time, most common in Escherichia coli, equally prevalent in ciprofloxacin-susceptible and -resistant strains, and not associated with qnr genes.

Antibiotic Resistance in BacteriaMycobacterium research and diagnosisAntimicrobial Resistance in StaphylococcusCiprofloxacinCeftazidimeEnterobacteriaceaeMicrobiologyEscherichia coliBiologyAntibacterial agentAntibioticsGeneBacteria

MeSH terms

AcetyltransferasesAnti-Bacterial AgentsCiprofloxacinCross-Sectional StudiesEnterobacteriaceaeEnterobacteriaceae InfectionsEscherichia coliKlebsiella pneumoniaeMicrobial Sensitivity TestsUnited StatesOdds RatioDrug Resistance, Bacterial

Funding

  • National Institutes of Health
  • U.S. Public Health Service
Citations
746
FWCI
12.13
field-weighted impact
References
14
Percentile
99%
vs. same field & year
Citations per year
Cited by
Antimicrobial Resistance in ESKAPE Pathogens
Clinical Microbiology Reviews · 2020 · 1,952 citations
The worldwide emergence of plasmid-mediated quinolone resistance
The Lancet Infectious Diseases · 2006 · 964 citations
Acquired Antibiotic Resistance Genes: An Overview
Frontiers in Microbiology · 2011 · 1,112 citations
Nanotechnology as a therapeutic tool to combat microbial resistance
Advanced Drug Delivery Reviews · 2013 · 1,372 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.